ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintSite TitleTitle ChevronIcon Twitter
Consumer Non-Durables

Takara Holdings Inc.

Business Summary

Takara Holdings, Inc. engages in the management of the operations of its subsidiaries. It operates through the following segments: Takara Shuzo Group, Takara Bio Group, Takara Healthcare, and Others. The Takara Shuzo Group segment provides alcoholic beverages and seasonings. The Takara Bio Group offers contract research services, and manufactures and sells research reagents, scientific instruments, and mushrooms. The Takara Healthcare segment deals with health food products. The Others segment handles the printing business. The company was founded in 1842 and is headquartered in Kyoto, Japan.

Financial Highlights

Mar 2020 JPYUSD
Revenue281,191M2,586.24M
Gross Profit108,617M998.99M
Operating income15,836M145.65M
Income before tax15,643M143.87M
Net income8,981M82.60M
EBITDA24,309M223.58M
Diluted EPS45.110.41
Dividends Per Share200.18
Total Assets283,882M2,629.63M
Total liabilities102,550M949.93M
Total equity147,763M1,368.74M
Operating cash flow11,744M108.01M
Currency in JPYCurrency in USD

Historical Data

 Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Revenue 225,364M 234,193M 268,142M 277,443M 281,191M
Gross Profit 88,312M 92,722M 102,879M 107,004M 108,617M
Operating income 11,680M 13,553M 15,614M 17,804M 15,836M
Income before tax 12,548M 14,520M 18,903M 17,658M 15,643M
Net income 7,055M 8,481M 11,029M 10,411M 8,981M
EBITDA 17,397M 19,310M 22,887M 25,159M 24,309M
Diluted EPS 35.06 42.14 54.97 52.15 45.11
Dividends Per Share 12 13 16 18 20
Total Assets 253,253M 274,368M 284,281M 287,106M 283,882M
Total liabilities 97,105M 108,444M 108,062M 107,308M 102,550M
Total equity 130,386M 135,043M 145,111M 148,198M 147,763M
Operating cash flow 10,373M 12,826M 16,265M 13,508M 11,744M
 Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Revenue 1,876.71M 2,162.69M 2,419.34M 2,501.86M 2,586.24M
Gross Profit 735.41M 856.25M 928.23M 964.91M 998.99M
Operating income 97.26M 125.15M 140.87M 160.54M 145.65M
Income before tax 104.49M 134.08M 170.55M 159.23M 143.87M
Net income 58.75M 78.31M 99.51M 93.88M 82.60M
EBITDA 144.87M 178.32M 206.50M 226.87M 223.58M
Diluted EPS 0.29 0.38 0.49 0.47 0.41
Dividends Per Share 0.09 0.12 0.14 0.16 0.18
Total Assets 2,253.24M 2,462.24M 2,673.06M 2,593.90M 2,629.63M
Total liabilities 863.96M 973.20M 1,016.09M 969.49M 949.93M
Total equity 1,160.06M 1,211.90M 1,364.46M 1,338.91M 1,368.74M
Operating cash flow 86.38M 118.44M 146.75M 121.80M 108.01M

Valuation Measures

Mar 2020
PER17.95
ROA3.14%
ROE6.06%
Operating margin5.63%
Profit margin3.19%

Key executives

  • President & Representative Director: Mutsumi Kimura
  • Executive Officer & Manager-Accounting: Shoumei Mitsui
  • Director & Manager-Business Administration: Keisuke Mori
  • Auditor: Minoru Washino
  • Auditor: Yuzo Watanabe

Shareholders

  • Nomura Asset Management Co., Ltd. (7.1%)
  • Mizuho Financial Group, Inc. (5.1%)
  • Japan Agricultural Cooperatives Group (4.7%)
  • Nikko Asset Management Co., Ltd. (3.5%)
  • Daiwa Asset Management Co. Ltd. (3.3%)
  • Rheos Capital Works, Inc. (Investment Management) (2.7%)
  • Meiji Yasuda Life Insurance Co. (2.6%)
  • The Bank of Kyoto, Ltd. (2.5%)
  • The Vanguard Group, Inc. (2.4%)
  • Sumitomo Mitsui Trust Asset Management Co., Ltd. (1.9%)

Contact Details

  • Website:http://www.takara.co.jp
  • Address: 20 Naginataboko-cho Shijo-dori, Karasuma Higashi-iru, Kyoto, 600-8688, Japan
  • Phone: +81.75.241.5130

Related Companies

  • Takara Shuzo International Co., Ltd.
  • Takara Butsuryu System Co. Ltd.
  • Taihei Butsuryu Co. Ltd.
  • J&W Hardie Ltd.
  • Takara Bussan Co., Ltd.
  • FOODEX SAS
  • Nagasaki Unso KK
  • Tazaki Foods Ltd.
  • Takara Network System Co. Ltd.
  • Tomatin Distillery Co. Ltd.
  • Luc CORPLtd
  • USA Takara Holding Co.
  • Takara Shuzo Co. Ltd.
  • Takara Sake USA, Inc.
  • Takara Group Employee Stock Ownership Plan
  • Kawahigashi Shoji Co., Ltd.
  • Takara Bio Inc.

Competitors

  • ZIOPHARM Oncology, Inc.
Last Updated on 4 Jun, 2020

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Get Unlimited access

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends April 30th

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media